These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1902 related articles for article (PubMed ID: 7907615)

  • 1. Prognostic significance of PCNA grade in malignant melanoma.
    Woosley JT; Dietrich DR
    J Cutan Pathol; 1993 Dec; 20(6):498-503. PubMed ID: 7907615
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic evaluation of cutaneous malignant melanoma: a clinicopathologic and immunohistochemical study.
    Niezabitowski A; Czajecki K; Ryś J; Kruczak A; Gruchała A; Wasilewska A; Lackowska B; Sokołowski A; Szklarski W
    J Surg Oncol; 1999 Mar; 70(3):150-60. PubMed ID: 10102344
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative analysis of proliferating cell nuclear antigen, bromodeoxyuridine, and mitotic index in uveal melanoma.
    Ghazvini S; Kroll S; Char DH; Frigillana H
    Invest Ophthalmol Vis Sci; 1995 Dec; 36(13):2762-7. PubMed ID: 7499099
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Morphometric, DNA, and proliferating cell nuclear antigen measurements in benign melanocytic lesions and cutaneous malignant melanoma.
    Björnhagen V; Bonfoco E; Brahme EM; Lindholm J; Auer G
    Am J Dermatopathol; 1994 Dec; 16(6):615-23. PubMed ID: 7864299
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The relationship between Fas/FasL and proliferating cell nuclear antigen expression and malignant degree in human melanoma].
    Wang YC; Tan Y
    Zhonghua Yi Xue Za Zhi; 2008 Apr; 88(14):965-8. PubMed ID: 18756968
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determination of proliferating fractions in malignant melanomas by anti-PCNA/cyclin monoclonal antibody.
    Takahashi H; Strutton GM; Parsons PG
    Histopathology; 1991 Mar; 18(3):221-7. PubMed ID: 1675189
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fas-mediated apoptosis of melanoma cells and infiltrating lymphocytes in human malignant melanomas.
    Shukuwa T; Katayama I; Koji T
    Mod Pathol; 2002 Apr; 15(4):387-96. PubMed ID: 11950912
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Proliferating cell nuclear antigen (PCNA/cyclin) in gastric carcinoma in relation to its prognosis].
    Li N
    Zhonghua Zhong Liu Za Zhi; 1993 Jan; 15(1):34-6. PubMed ID: 8101481
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of proliferative activity as assessed by proliferating cell nuclear antigen (PCNA) and Ki-67 monoclonal antibodies in melanocytic skin lesions. A quantitative immunohistochemical study.
    Rieger E; Hofmann-Wellenhof R; Soyer HP; Kofler R; Cerroni L; Smolle J; Kerl H
    J Cutan Pathol; 1993 Jun; 20(3):229-36. PubMed ID: 8103531
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proliferating cell nuclear antigen in hepatocellular carcinoma and small cell liver dysplasia.
    Adachi E; Hashimoto H; Tsuneyoshi M
    Cancer; 1993 Nov; 72(10):2902-9. PubMed ID: 8106139
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparative assessment of proliferating cell nuclear antigen, c-myc p62, and nucleolar organizer region staining in non-Hodgkin's lymphomas: a histochemical and immunohistochemical study of 200 cases.
    Korkolopoulou P; Patsouris E; Pangalis G; Tsenga A; Elemenoglou J; Thomas-Tsangli E; Spandidos D; Kittas C
    Hum Pathol; 1993 Apr; 24(4):371-7. PubMed ID: 7684020
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunohistochemical study of Spitz nevi and malignant melanoma with use of antibody to proliferating cell nuclear antigen.
    Niemann TH; Argenyi ZB
    Am J Dermatopathol; 1993 Oct; 15(5):441-5. PubMed ID: 7902020
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic significance of proliferating cell nuclear antigen-positive growth fraction in gastric adenomas.
    Kim WH; Choe GY; Kim YI
    J Korean Med Sci; 1992 Sep; 7(3):199-203. PubMed ID: 1363046
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proliferative activity of cutaneous melanocytic neoplasms defined by a proliferating cell nuclear antigen labelling index.
    Tokuda Y; Mukai K; Matsuno Y; Furuya S; Shimosato Y; Takasaki Y; Saida T; Ishihara K
    Arch Dermatol Res; 1992; 284(6):319-23. PubMed ID: 1363460
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytomorphological variations, proliferation and angiogenesis in the prognosis of cutaneous melanoma.
    Jonjic N; Zamolo G; Stifter S; Fuckar D; Gruber F; Sasso F; Rizzardi C; Melato M
    Clin Exp Dermatol; 2003 May; 28(3):310-4. PubMed ID: 12780721
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proliferating cell nuclear antigen distribution in keratoacanthoma and squamous cell carcinoma.
    Phillips P; Helm KF
    J Cutan Pathol; 1993 Oct; 20(5):424-8. PubMed ID: 7507945
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic value of ploidy and proliferation markers in renal cell carcinoma.
    Tannapfel A; Hahn HA; Katalinic A; Fietkau RJ; Kühn R; Wittekind CW
    Cancer; 1996 Jan; 77(1):164-71. PubMed ID: 8630925
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunohistochemical analysis of proliferating cell nuclear antigen, p53 protein and nm23 protein, and nuclear DNA content in transitional cell carcinoma of the bladder.
    Shiina H; Igawa M; Nagami H; Yagi H; Urakami S; Yoneda T; Shirakawa H; Ishibe T; Kawanishi M
    Cancer; 1996 Oct; 78(8):1762-74. PubMed ID: 8859190
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Poor prognostic value of proliferating cell nuclear antigen labelling index in breast carcinoma.
    Thomas M; Noguchi M; Kitagawa H; Kinoshita K; Miyazaki I
    J Clin Pathol; 1993 Jun; 46(6):525-8. PubMed ID: 8101192
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic value of proliferating cell nuclear antigen (PCNA) in infiltrating ductal carcinoma breast.
    Aziz SA; Pervez S; Khan SM; Kayani N; Nasir MI
    J Coll Physicians Surg Pak; 2005 Apr; 15(4):225-9. PubMed ID: 15857596
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 96.